Daicel Pharma Services provides innovative analytical solutions to support timely and safe drug development with improved cost efficiency. We support the domestic and global pharmaceutical industry from the development stage to commercialized products.

We have a dedicated and experienced team of analytical scientists and a quality assurance team capable of providing documentation support – CMC, IND-CTA, EMA, DMF, and ANDA – in line with global regulatory requirements for both drug substance and drug product (US FDA, EU and Brazilian) filings.

A wholly-owned and operated subsidiary of Daicel Corporation, Japan, our facility offers a wide range of Analytical Research and Development services.

We are continually evolving to meet the changing world